Profile data is unavailable for this security.
About the company
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
- Revenue in EUR (TTM)17.83bn
- Net income in EUR900.00m
- Incorporated2000
- Employees64.82k
- LocationRoyal PhilipsHigh Tech Campus 5EINDHOVEN 5656 AENetherlandsNLD
- Phone+31 205977777
- Websitehttps://www.philips.com/
More ▼
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| SpectraWAVE Inc | 13.81% | -- |
Data delayed at least 15 minutes, as of Feb 16 2026 16:37 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Demant A/S | 3.08bn | 317.00m | 5.04bn | 26.70k | 15.72 | 3.78 | -- | 1.64 | 11.21 | 7.31 | 108.71 | 46.67 | 0.6423 | 2.19 | 5.94 | 860,208.20 | 6.62 | 8.82 | 8.18 | 12.44 | 75.62 | 75.44 | 10.30 | 12.49 | 1.00 | 5.69 | 0.6791 | 0.00 | 2.46 | 9.69 | -18.09 | 16.13 | 5.16 | -- |
| ConvaTec Group PLC | 1.99bn | 182.60m | 5.11bn | 10.48k | 29.42 | 3.51 | 13.83 | 2.57 | 0.0773 | 0.0773 | 0.84 | 0.6474 | 0.637 | 2.74 | 6.31 | 164,651.80 | 5.86 | 3.35 | 6.63 | 3.91 | 55.90 | 55.73 | 9.20 | 5.88 | 1.15 | 4.78 | 0.4252 | 94.67 | 6.85 | 4.61 | 46.20 | 81.02 | 14.74 | 1.20 |
| BioMerieux SA | 4.12bn | 377.90m | 10.98bn | 14.75k | 29.19 | 2.78 | 12.85 | 2.66 | 3.18 | 3.18 | 34.66 | 33.32 | 0.7715 | 1.81 | 5.96 | 279,368.30 | 6.94 | 9.22 | 8.56 | 11.94 | 56.27 | 56.58 | 8.99 | 12.35 | 1.30 | 43.19 | 0.1139 | 20.24 | 8.31 | 8.27 | 20.86 | 9.64 | 4.88 | 36.49 |
| Smith & Nephew plc | 5.01bn | 413.75m | 12.92bn | 17.00k | 32.32 | 2.86 | 13.50 | 2.58 | 0.4091 | 0.4091 | 4.95 | 4.63 | 0.5599 | 0.7184 | 4.26 | 251,036.30 | 4.62 | 3.62 | 5.48 | 4.41 | 70.04 | 70.47 | 8.26 | 7.10 | 1.40 | 7.24 | 0.3842 | 87.54 | 4.70 | 2.49 | 56.65 | -7.24 | -1.36 | -2.01 |
| Sonova Holding AG | 4.22bn | 571.19m | 12.95bn | 18.04k | 22.72 | 4.86 | 15.28 | 3.07 | 8.71 | 8.71 | 64.41 | 40.72 | 0.7019 | 2.42 | 7.21 | 213,874.40 | 9.62 | 10.74 | 12.57 | 13.66 | 71.66 | 72.16 | 13.71 | 17.50 | 0.9087 | 16.87 | 0.377 | 42.61 | 6.58 | 5.79 | -10.07 | 5.22 | 1.33 | -- |
| Coloplast A/S | 3.73bn | 533.99m | 13.75bn | 16.98k | 27.59 | 7.98 | 18.81 | 3.68 | 17.71 | 17.71 | 123.79 | 61.25 | 0.5743 | 2.38 | 6.12 | 1,625,729.00 | 8.21 | 12.75 | 10.44 | 17.10 | 67.87 | 67.86 | 14.30 | 18.95 | 0.8122 | 9.75 | 0.6451 | 100.37 | 3.12 | 8.49 | -28.03 | -2.83 | 8.92 | 5.02 |
| Sartorius AG | 3.52bn | 133.70m | 15.51bn | 13.88k | 94.53 | 4.74 | 24.31 | 4.41 | 1.94 | 1.94 | 51.09 | 38.65 | 0.3625 | 2.22 | 11.51 | 260,001.50 | 2.16 | 6.19 | 2.91 | 8.65 | 46.48 | 49.69 | 5.95 | 12.35 | 0.4922 | 2.89 | 0.5282 | 22.30 | -0.4417 | 13.10 | -59.14 | -11.72 | 12.69 | 15.84 |
| Sartorius Stedim Biotech SA | 2.95bn | 264.10m | 17.03bn | 10.13k | 64.77 | 4.22 | 29.36 | 5.78 | 2.70 | 2.70 | 30.14 | 41.48 | 0.3712 | 2.18 | 11.69 | 297,606.30 | 3.34 | 8.62 | 3.86 | 10.54 | 45.64 | 49.34 | 9.00 | 15.34 | 0.5024 | 3.80 | 0.3863 | 20.94 | 0.1621 | 14.05 | -43.57 | -5.67 | 20.10 | 15.21 |
| Straumann Holding AG | 2.83bn | 469.74m | 17.05bn | 11.95k | 36.34 | 7.55 | 26.64 | 6.02 | 2.68 | 2.47 | 16.15 | 12.90 | 0.7378 | 1.72 | 4.23 | 218,270.60 | 12.29 | 12.06 | 16.00 | 15.54 | 71.24 | 74.11 | 16.65 | 17.39 | 1.13 | 10.42 | 0.1743 | 32.23 | 9.98 | 9.42 | 2.11 | 8.35 | 2.28 | 10.56 |
| Koninklijke Philips NV | 17.83bn | 900.00m | 25.18bn | 64.82k | 27.90 | 2.27 | 12.44 | 1.41 | 0.9371 | 0.9317 | 18.65 | 11.52 | 0.6378 | 3.22 | 4.95 | 275,143.90 | 3.22 | -0.9494 | 4.48 | -1.30 | 45.18 | 44.19 | 5.05 | -1.57 | 0.9405 | 8.09 | 0.4239 | -- | -1.04 | 0.5947 | 206.52 | -1.93 | -5.68 | -- |
| Alcon AG | 8.58bn | 881.88m | 33.39bn | 25.60k | 37.67 | 1.78 | 16.82 | 3.89 | 1.62 | 1.62 | 15.73 | 34.27 | 0.3292 | 1.94 | 5.58 | 305,323.20 | 3.38 | 1.51 | 3.71 | 1.66 | 54.26 | 54.08 | 10.28 | 5.03 | 1.30 | 17.58 | 0.1917 | 25.74 | 4.82 | 5.71 | 4.52 | -- | -0.1782 | -- |
| Siemens Healthineers AG | 23.30bn | 2.12bn | 45.89bn | 72.80k | 21.59 | 2.49 | 12.98 | 1.97 | 1.88 | 1.88 | 20.72 | 16.34 | 0.5032 | 3.18 | 3.73 | 319,109.60 | 4.63 | 4.33 | 6.37 | 5.86 | 38.44 | 37.61 | 9.20 | 8.82 | 0.7162 | 10.64 | 0.4426 | 53.94 | 4.53 | 10.08 | 10.40 | 8.73 | 7.99 | 4.56 |
| EssilorLuxottica SA | 28.49bn | 2.32bn | 119.67bn | 200.00k | 51.78 | 3.08 | 21.58 | 4.20 | 4.99 | 4.99 | 61.31 | 83.99 | 0.4446 | 3.43 | 8.26 | 142,455.00 | 3.81 | 3.71 | 4.69 | 4.46 | 59.69 | 61.57 | 8.57 | 9.01 | 0.6966 | 17.40 | 0.2672 | -- | 7.48 | 14.58 | -1.87 | 93.65 | 18.60 | -- |
Data as of Feb 16 2026. Currency figures normalised to Royal Philips's reporting currency: Euro EUR
26.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 28 Jun 2024 | 94.13m | 9.78% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 28.79m | 2.99% |
| Edgepoint Investment Group, Inc.as of 30 Jun 2025 | 26.19m | 2.72% |
| BlackRock Fund Advisorsas of 09 Feb 2026 | 22.04m | 2.29% |
| Causeway Capital Management LLCas of 31 Dec 2025 | 19.29m | 2.00% |
| Dodge & Coxas of 31 Dec 2025 | 18.13m | 1.88% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 14.24m | 1.48% |
| T. Rowe Price International Ltd.as of 05 Feb 2026 | 13.28m | 1.38% |
| Pzena Investment Management LLCas of 30 Nov 2025 | 11.55m | 1.20% |
| BlackRock Advisors (UK) Ltd.as of 09 Feb 2026 | 9.51m | 0.99% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
